(Q34518168)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

treatment-resistant depression

20 January 2020

main subject

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

Helen S Mayberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Charles B Nemeroff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Scott E Krahl

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

James McNamara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Alan Frazer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Mark S George

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Dennis S Charney

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Stephen K Brannan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

19 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

1345-1355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301082

20 January 2020

exact match

0 references

cites work

Functional and chemical anatomy of the afferent vagal system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Depression, mortality, and medical morbidity in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

A review of functional neuroimaging studies of vagus nerve stimulation (VNS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

How do you feel? Interoception: the sense of the physiological condition of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Neuropsychological processing associated with recovery from depression after stereotactic subcaudate tractotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Vagus nerve stimulation is associated with mood improvements in epilepsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Mechanisms of action of vagus nerve stimulation (VNS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Vagus nerve stimulation. A potential therapy for resistant depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Vagus nerve stimulation: a new tool for brain research and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Electrophysiological studies of cervical vagus nerve stimulation in humans: I. EEG effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Therapeutic mechanisms of vagus nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Brain blood-flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: II. prolonged effects at high and low levels of stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

[Electric brain stimulation for epilepsy therapy].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Seizure inhibition by median raphe nucleus stimulation in rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

ECT in the treatment of status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Depression: a role for neurosurgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Deep brain stimulation for treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Burden of disease--implications for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Acute vagus nerve stimulation using different pulse widths produces varying brain effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Decreased regional brain metabolism after ect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Effectiveness of electroconvulsive therapy in community settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Electroconvulsive therapy and newer modalities for the treatment of medication-refractory mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Poststroke depression: prevalence, diagnosis, treatment, and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Vagus nerve stimulation for treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Serotonergic inhibition of amygdala-kindled seizures in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

7 January 2021

Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

7 January 2021

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

7 January 2021

A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

7 January 2021

Vagus nerve stimulation and refractory depression: please can you switch me on doctor?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

7 January 2021

Evidence implicating substantia nigra in regulation of kindled seizure threshold.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

7 January 2021

Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

7 January 2021

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

7 January 2021

Vagus nerve stimulation for the treatment of medically intractable seizures. Results of a 1-year open-extension trial. Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301082

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301082

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16641939%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 January 2020

1013195159

0 references

1 reference